Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy
Amy J. Wisdom(Duke Medical Center), David G. Kirsch(Duke University), Xiaodi Qin(Duke Cancer Institute), Ash A. Alizadeh(California Institute for Regenerative Medicine), Jonathon E. Himes(Duke Medical Center), Kimberly S. Smythe(Fred Hutch Cancer Center), Hèléne Fradin(North Carolina Biotechnology Center), Barzin Y. Nabet(Gene Therapy Laboratory), Eric S. Muise(Merck & Co., Inc., Rahway, NJ, USA (United States)), Rutulkumar Patel(Duke Medical Center), Alex M. Bassil(Duke Medical Center), Kouros Owzar, Yan Ma(Chinese University of Hong Kong), Collin Kent(Duke Medical Center), Daniel A. King(Northwell Health), Cierra S. Hong(Duke Medical Center), Yvonne M. Mowery(Duke University), Nerissa T. Williams(Duke Medical Center), David Carpenter(WellStar Health System), Lixia Luo(Duke Medical Center), Eric S. Xu(Duke Medical Center), Lan Chen(Guiyang Medical University), Todd Bradley(University of Kansas Medical Center), Dadong Zhang(Duke Cancer Institute), Maximilian Diehn(California Institute for Regenerative Medicine)
Cited by 112
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia
|The Journal of Experimental Medicine|2001|1.1k
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
|Cancer Cell|2021|930
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
|Journal of Clinical Oncology|2018|925